These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23621659)

  • 21. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.
    Olsen EA; Kim YH; Kuzel TM; Pacheco TR; Foss FM; Parker S; Frankel SR; Chen C; Ricker JL; Arduino JM; Duvic M
    J Clin Oncol; 2007 Jul; 25(21):3109-15. PubMed ID: 17577020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisal.
    Noe MH; Drake A; Link BK; Liu V
    J Cutan Pathol; 2013 Aug; 40(8):714-9. PubMed ID: 23651057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis.
    Smith BD; Wilson LD
    Oncology (Williston Park); 2003 Sep; 17(9):1281-8. PubMed ID: 14569854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocosis fungoides--an update on a non-mycotic disease.
    Makdisi J; Friedman A
    J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycosis fungoides and the Sézary syndrome.
    Kim YH; Hoppe RT
    Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
    Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
    Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversies in the management of the cutaneous T cell lymphomas.
    Zic JA
    Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.
    Querfeld C; Rosen ST; Kuzel TM; Guitart J
    Semin Cutan Med Surg; 2003 Sep; 22(3):150-61. PubMed ID: 14649582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
    Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
    J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.
    Chandra P; Plaza JA; Zuo Z; Diwan AH; Koeppen H; Duvic M; Medeiros LJ; Prieto VG
    Am J Clin Pathol; 2009 Apr; 131(4):511-5. PubMed ID: 19289586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-transplant cutaneous T-cell lymphomas.
    Lok C; Viseux V; Denoeux JP; Bagot M
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):137-45. PubMed ID: 16046144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis and staging of cutaneous T-cell lymphoma.
    Foss FM; Sausville EA
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1011-9. PubMed ID: 8522481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two cases of syringotropic cutaneous T-cell lymphoma and review of the literature.
    Yost JM; Do TT; Kovalszki K; Su L; Anderson TF; Gudjonsson JE
    J Am Acad Dermatol; 2009 Jul; 61(1):133-8. PubMed ID: 19539851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
    Ponte P; Serrão V; Apetato M
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept.
    Schmid MH; Bird P; Dummer R; Kempf W; Burg G
    Arch Dermatol; 1999 Oct; 135(10):1204-8. PubMed ID: 10522667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous T cell lymphoma.
    Worobec-Victor SM
    N J Med; 1989 May; 86(5):395-400. PubMed ID: 2662058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of cutaneous lymphomas in a medical center in Bahia, Brazil.
    Bittencourt AL; Oliveira PD; Andrade AC; Santos TC; Oliveira RF; Farré L; Araujo I
    Am J Clin Pathol; 2013 Sep; 140(3):348-54. PubMed ID: 23955453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.